Related Experiment Videos
Andinermals A-C, antiplasmodial constituents from Andira inermis
C Kraft1, K Jenett-Siems, K Siems
1Institut für Pharmazie (Pharmazeutische Biologie), Freie Universität Berlin, Königin-Luise-Str. 2-4, D-14195, Berlin, Germany.
Phytochemistry
|October 24, 2001
Summary
Researchers screened Andira inermis leaves for malaria treatments, isolating novel compounds. Three new 2-arylbenzofuran-3-carbaldehydes and a flavanonol glycoside were identified from the herbal remedy screening.
Area of Science:
- Phytochemistry
- Pharmacognosy
- Medicinal Chemistry
Background:
- Traditional medicine utilizes Andira inermis for treating malaria.
- Screening programs are essential for identifying novel bioactive compounds from medicinal plants.
Purpose of the Study:
- To isolate and characterize phenolic compounds from Andira inermis leaves.
- To investigate the potential of these compounds as antimalarial agents based on traditional use.
Main Methods:
- Bioassay-guided fractionation of Andira inermis leaf extracts.
- Isolation and purification of phenolic compounds using chromatographic techniques.
- Structure elucidation of isolated compounds using spectroscopic methods.
Main Results:
- Three novel 2-arylbenzofuran-3-carbaldehydes, named andinermal A-C, were isolated.
- A new flavanonol glycoside, taxifolin-3-O-(3"-O-trans-cinnamoyl)-alpha-L-rhamnopyranoside, was identified.
- The isolated compounds are phenolic in nature, aligning with the study's focus.
Conclusions:
- The study successfully identified novel phenolic compounds from Andira inermis.
- These findings contribute to the scientific validation of Andira inermis as a traditional antimalarial remedy.
- Further investigation into the bioactivity of these isolated compounds is warranted.